Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor
HomeCorrection: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor
Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor
Chang,Matossian,Elliott,Burks,Sabol,Ucar,Wathieu,Zabaleta,Valle,Gill,Martin,Riker,Miele,Bunnell,Burow,and Collins-Burow: Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor
The ninth author’s name is spelled incorrectly. The correct name is: Luis Del Valle.
The author’s initials are also indexed incorrectly in PubMed. The correct initials are: Del Valle L.
Reference
1
TCChang, MDMatossian, SElliott, HEBurks, RASabol, DAUcar, et al. (2020) Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor. PLoS ONE15(10): e0226464. 10.1371/journal.pone.0226464
Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor
Facebook
Twitter
Linkedin
Whatsapp
